COBISS Co-operative Online Bibliographic system & services COBISS
Tina Karun
Personal bibliography for the period 2020-2025
2020
1.
KARUN, Tina. Laboratorijsko delo v praksi : dnevnik. Kranj: [T. Karun], 2020. 30 str., ilustr. [COBISS.SI-ID 24141827]
2022
2.
KARUN, Tina, LEVSTEK, Tina, REHBERGER LIKOZAR, Andreja, ŠEBEŠTJEN, Miran, TREBUŠAK
PODKRAJŠEK, Katarina. Vpliv zaviralcev PCSK9 na raven plazemskih nekodirajočih mikroRNA
pri bolnikih z zelo visokimi vrednostmi lipoproteina(a). In: BAVEC, Aljoša (ed.),
et al. BIOmolekularec.si : dan biomolekularnih znanosti : zbornik povzetkov : Ljubljana,
29. september 2022. Ljubljana: Slovensko biokemijsko društvo, 2022. Str. 44. ISBN 978-961-95941-0-0.
http://biomolekularec.splet.arnes.si/files/2022/09/BIOmolekularec_2022-zbornik.pdf. [COBISS.SI-ID 122422787]
2023
3.
LEVSTEK, Tina, KARUN, Tina, REHBERGER LIKOZAR, Andreja, ŠEBEŠTJEN, Miran, TREBUŠAK
PODKRAJŠEK, Katarina (author, corresponding author). Interplay between microRNAs,
serum proprotein convertase subtilisin/kexin type 9 (PCSK9), and lipid parameters
in patients with very high lipoprotein(a) treated with PCSK9 inhibitors. Genes. 2023, vol. 14, iss. 3, [article no.] 632, 1-13 str., tabele. ISSN 2073-4425. https://www.mdpi.com/2073-4425/14/3/632, DOI: 10.3390/genes14030632. [COBISS.SI-ID 144230147]
project: P3-0308, P1-0170; funder: Slovenian Research Agency
project: 20220011; funder: University Medical Centre Ljubljana
project: Sofinancerja: Amgen, Sanofi
project: P3-0308, P1-0170; funder: Slovenian Research Agency
project: 20220011; funder: University Medical Centre Ljubljana
project: Sofinancerja: Amgen, Sanofi
4.
LEVSTEK, Tina, KARUN, Tina, JADRIČ, Nina, PODKRAJŠEK, Nik, REHBERGER LIKOZAR, Andreja,
ŠEBEŠTJEN, Miran, TREBUŠAK PODKRAJŠEK, Katarina. Treatment with PCSK9 inhibitors affects
expression of microRNAs in patients with very high lipoprotein(a) levels. In: GORIČAR,
Katja (ed.), et al. Biochemistry and molecular genetics in medicine : Scientific Symposium with International
Participation on the Occasion of the 50th Anniversary of the Institute of Biochemistry
and Molecular Genetics (1972-2022) and the 30th Anniversary of the Medical Centre
for Molecular Biology (1992-2022) at the Faculty of Medicine, University of Ljubljana
: 6.-7. 7. 2023, Large lecture hall, Faculty of Medicine, Korytkova 2, Ljubljana. Electronic version. Ljubljana: Faculty of Medicine, 2023. Str. 64-65. ISBN 978-961-267-243-0.
https://www.mf.uni-lj.si/application/files/6516/8858/1409/Biochemistry_and_Molecular_Genetics_in_Medicine_proceedings.pdf. [COBISS.SI-ID 158193155]
2024
5.
KARUN, Tina. Vpliv genetske variabilnosti in izražanja specifičnih mikroRNA na koncentracije PCSK9
med zdravljenjem z zaviralci PCSK9 = The effect of genetic variation and specific
microRNA expression on PCSK9 concentrations during treatment with PCSK9 inhibitors
: magistrski študijski program Laboratorijska biomedicina. Ljubljana: [T. Karun], 2024. III, 66 str., tabele. [COBISS.SI-ID 198554627]
2025
6.
REHBERGER LIKOZAR, Andreja, LEVSTEK, Tina, KARUN, Tina, TREBUŠAK PODKRAJŠEK, Katarina,
ZUPAN, Janja, ŠEBEŠTJEN, Miran. Treatment with PCSK9 inhibitors influences microRNAs
expression and changes of arterial wall properties : a randomized controlled trial.
European journal of medical research. [Online ed.]. 2025, vol. 30, [article no.] 138, 1 spletni vir (1 datoteka pdf (
9 str.)), ilustr. ISSN 2047-783X. https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-025-02398-6, Repository of the University of Ljubljana – RUL , DiRROS - Digital repository of Slovenian research organizations, DOI: 10.1186/s40001-025-02398-6. [COBISS.SI-ID 231157507]
project: This study was funded by Amgen, Sanofi, the Slovenian Research Agency research programs P3-0308 and P1-0170, and the University Medical Centre Ljubljana (funding number 20240051).
project: This study was funded by Amgen, Sanofi, the Slovenian Research Agency research programs P3-0308 and P1-0170, and the University Medical Centre Ljubljana (funding number 20240051).